Hb Bristol-Alesha presenting thalassemia-type hyperunstable hemoglobinopathy

International Journal of Hematology

Volumn 80, Issue 5, 2004, Pages 410-415

  Kano, Gen ^a   Morimoto, Akira ^a   Hibi, Shigeyoshi ^a   Tokuda, Chika ^a   Todo, Shinjiro ^a   Sugimoto, Tohru ^a   Harano, Teruo ^b   Miyazaki, Ayako ^c   Shimizu, Akira ^c   Imashuku, Shinsaku ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d Kyoto City Institute of Health and Environmental Sciences   (Japan)

Author keywords

Hb Bristol; Hb Bristol Alesha; Hyperunstable hemoglobin; Posttranslational modification

Indexed keywords

BETA GLOBIN; HEMOGLOBIN BRISTOL ALESHA; HEMOGLOBIN VARIANT; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BETA CHAIN; CASE REPORT; DNA SEQUENCE; GLOBIN GENE; HUMAN; INFANT; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PROTEIN MODIFICATION; PROTEIN STABILITY; THALASSEMIA;

AMINO ACID SUBSTITUTION; ANEMIA, HEMOLYTIC; BLOOD TRANSFUSION; DNA MUTATIONAL ANALYSIS; HEMOGLOBINOPATHIES; HEMOGLOBINS, ABNORMAL; HUMANS; INFANT; MALE; POINT MUTATION; PROGNOSIS; SPLENECTOMY; SPLENOMEGALY; THALASSEMIA;

EID: 19944427461     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04048     Document Type: Article

References (24)

1. Hörlein H, Weber G. Über chromische familiäre Methamoglobinämie und eine neue Modifikation des methämoglobins. Dtch Med Wochenschr. 1948;73:4.
2. Pauling L. Sickle cell anemia: a molecular disease. Science. 1949; 110:543.
3. Huisman TH, Carver MF, Efremov GD. A Syllabus of Human Hemoglobin Variants. 2nd ed. Augusta, GA: Sickle Cell Anemia Foundation; 1998.
4. Steadman JH, Yates A, Huehns ER. Idiopathic Heinz body anemia: Hb-Bristol (β67 (E11) Val to Asp). Br J Haematol. 1970;18: 435-446.
5. Molchanova TP, Postnikov Yu V, Pobedimskaya DD, et al. Hb Alesha or α2 β(2)67(E11)Val→Met: a new unstable hemoglobin variant identified through sequencing of amplified DNA. Hemoglobin. 1993;17:217-225.
6. Rees DC, Rochette J, Schofield C, et al. A novel silent posttranslational mechanism converts methionine to aspartate in hemoglobin Bristol (β67[E11]Val→Asp). Blood. 1996;88:341-348.
7. Hutt PJ, Fairbanks VF, Thibodeau SN, et al. Hb T-Cambodia, a β chain variant with the mutations of Hb E and Hb D-Punjab, confirmed by DNA analysis. Hemoglobin. 1997;21:205-218.
8. Miyazaki A, Nakanishi T, Shimizu A, Hisamitsu H. First case of a single heterozygote of an abnormal hemoglobin, Hb Stanmore. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;792:23-31.
9. Miyazaki A, Nakanishi T, Kishikawa M, et al. Post-translational modification from methionine to aspartic acid-residue on a variant hemoglobin, Hb Bristol, a proof by ES1-MS-MS. J Mass Spectrom. 1996;31:1311-1313.
10. Ohba Y, Hattori Y, Harano T, Harano K, Fukumaki Y, Ideguchi H. β-Thalassemia mutations in Japanese and Koreans. Hemoglobin. 1997;21:191-200.
11. Cathie I. Apparent idiopathic Heinz body anemia. Great Ormond St J. 1952;3:43-47.
12. Sakuragawa M, Ohba Y, Miyaji T, Yamamoto K, Miwa S. A Japanese boy with hemolytic anemia due to an unstable hemoglobin (Hb Bristol). Nippon Ketsueki Gakkai Zasshi. 1984;47:896-902.
13. Ohba Y, Matsuoka M, Miyaji T, Shibuya T, Sakuragawa M. Hemoglobin Bristol or β67(E11)Val→Asp in Japan. Hemoglobin. 1985; 9:79-85.
14. Aseeva EA, Lutsenko IN, Pivnik AV, Spivak VA, Beliaeva LS, Zhestkova NM. Congenital hemolytic anemia caused by the carriage of hemoglobin Bristol β67 Bal→Asp. Ter Arkh. 1993;64: 78-81.
15. Thein SL. Is it dominantly inherited β thalassaemia or just a β-chain variant that is highly unstable? Br J Haematol. 1999;107: 12-21.
16. Thein SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body β-thalassemia. Proc Natl Acad Sci U S A. 1990;87:3924-3928.
17. Podda A, Galanello R, Maccioni L, et al. Hemoglobin Cagliari (β60 [E4] Val→Glu): a novel unstable thalassemic hemoglobinopathy. Blood. 1991;15:371-375.
18. Baird M, Schreiner H, Driscoll C, Bank A. Localization of the site of recombination in formation of Lepore Boston globin gene. J Clin Invest. 1981;68:560-564.
19. Orkin SH, Antonakaris SE, Loukopoulaos D. Abnormal processing of β Knossos RNA. Blood. 1984;64:311-313.
20. Orkin SH, Kazarian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP. Abnormal RNA processing due to the exon mutation of β E-globin gene. Nature. 1982;300:768-769.
21. Weiss IM, Liebhaber SA. Erythroid cell-specific mRNA stability elements in the α2-globin 3′ nontranslated region. Mol Cell Biol. 1995;15:2457-2465.
22. Wajcman H, Vasseur C, Blouquit Y, et al. Hemoglobin Redondo [β92 (F8) His→Asn]: an unstable hemoglobin variant associated with heme loss which occurs in two forms. Am J Hematol. 1991;38: 194-200.
23. Brenann SO, Shaw J, Allen J, George PM. Beta 141 Leu is not deleted in the unstable haemoglobin Atlanta-Coventry but is replaced by a novel amino acid of mass 129 daltons. Br J Haematol. 1992;81:99-103.
24. Perutz MF. Frequency of abnormal human hemoglobins caused by C→T transitions in CpG dinucleotides. J Mol Biol. 1990;213: 203-206.